Can a single gene therapy injection hold back wet AMD for years?
Disease control
Recruiting now
This study follows people with wet age-related macular degeneration who received an injection of SKG0106, an experimental gene therapy, in an earlier trial. Researchers will track their eye health, vision, and any side effects for up to 5 years after the injection. The goal is to…
Sponsor: Skyline Therapeutics • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC